HIGHLIGHTS
- who: Annelies Verbon and collaborators from the Department of Internal Medicine, Division of Infectious Diseases, Center for Infection and Immunity, Academic Medical Center, University of Amsterdam, Amsterdam, of Amsterdam, Amsterdam, The Netherlands have published the Article: No Treatment versus 24 or 60 Weeks of Antiretroviral Treatment during Primary HIV Infection: The Randomized Primo-SHM Trial, in the Journal: (JOURNAL) of March/27,/2012
- what: The aim of this study was to assess the benefit of temporary combination antiretroviral therapy (cART) during primary HIV infection (PHI). The study was designed to evaluate the effect of temporary . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.